ScoreWhy is Jubilant Pharmova Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate -6.55% of over the last 5 years
2
Flat results in Sep 25
- DEBTORS TURNOVER RATIO(HY) Lowest at 0.79 times
3
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 1.80% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -11.92% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Jubilant Pharmo for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Jubilant Pharmo
-11.75%
-0.31
38.53%
Sensex
4.67%
0.39
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
0.71%
EBIT Growth (5y)
-6.55%
EBIT to Interest (avg)
3.63
Debt to EBITDA (avg)
3.16
Net Debt to Equity (avg)
0.34
Sales to Capital Employed (avg)
0.77
Tax Ratio
30.36%
Dividend Payout Ratio
102.46%
Pledged Shares
5.40%
Institutional Holding
27.09%
ROCE (avg)
9.12%
ROE (avg)
6.76%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
34
Industry P/E
34
Price to Book Value
2.59
EV to EBIT
22.09
EV to EBITDA
15.29
EV to Capital Employed
2.18
EV to Sales
2.54
PEG Ratio
1.24
Dividend Yield
0.47%
ROCE (Latest)
9.88%
ROE (Latest)
7.56%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
DPR(Y)
Highest at 414.06%
OPERATING PROFIT TO INTEREST(Q)
Highest at 6.80 times
NET SALES(Q)
Highest at Rs 1,966.40 cr
PBT LESS OI(Q)
At Rs 186.30 cr has Grown at 36.08%
-4What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 0.79 times
Loading Valuation Snapshot...
Here's what is working for Jubilant Pharmo
Operating Profit to Interest - Quarterly
Highest at 6.80 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Dividend Payout Ratio (DPR) - Annually
Highest at 414.06% and Grown
each year in the last five yearsMOJO Watch
Company is distributing higher proportion of profits generated as dividend
DPR (%)
Net Sales - Quarterly
Highest at Rs 1,966.40 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 186.30 cr has Grown at 36.08%
Year on Year (YoY)MOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Here's what is not working for Jubilant Pharmo
Debtors Turnover Ratio- Half Yearly
Lowest at 0.79 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
